During the past decade, Global Alliance of Regenerative Medicine (GARM) International conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Global Alliance of Regenerative Medicine (GARM) International" #1 collaborator was "Global Alliance for Regenerative Medicine" with 1 trials as a collaborator and "Robert W. Alexander, MD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Global Alliance of Regenerative Medicine (GARM) International" are "Autoimmune" (1 trials), "COPD" (1 trials), "Multiple Sclerosis" (1 trials) and "Respiratory Insufficiency" (1 trials). Many other conditions were trialed in "Global Alliance of Regenerative Medicine (GARM) International" in a lesser frequency.

Most popular intervention types in "Global Alliance of Regenerative Medicine (GARM) International" are "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AD-cSVF" (1 trials), "Centricyte 1000" (1 trials), "Lipoaspiration" (1 trials), "Microcannula Harvest Adipose Stroma" (1 trials) and "Normal Saline IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Global Alliance of Regenerative Medicine (GARM) International" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Global Alliance of Regenerative Medicine (GARM) International". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Global Alliance of Regenerative Medicine (GARM) International, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Global Alliance of Regenerative Medicine (GARM) International, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".